— Know what they know.
Not Investment Advice

SLDB NASDAQ

Solid Biosciences Inc.
1W: -6.0% 1M: -33.4% 3M: -38.1% YTD: +25.7% 1Y: +16.7% 3Y: +174.0% 5Y: -82.9%
$6.85
-0.13 (-1.86%)
 
Weekly Expected Move ±7.9%
$6 $6 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 29 · $674.4M mcap · 78M float · 1.91% daily turnover · Short 57% of daily vol

Supply Chain Overview

7 relationships
7
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-06-16
Earliest Filing
2022-12-05
Latest Filing
supplier: 3 target: 2 acquirer: 1 partner: 1

Counterparties (Filed by SLDB)

7 relationships

Companies named in SLDB's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
AavantiBio — target Target company acquired by Solid Biosciences Inc. via merger 2022-12-05 View
University of Florida Research Foundation — supplier Licensor of patent rights and know-how for AAV vectors and treatments 2022-12-05 View
Life Technologies Corporation TH supplier Licensor of life cells for producing genetically engineered AAV particles 2022-12-05 View
University of North Carolina — supplier Licensor of patent rights relating to truncated dysferlin for treatment of dysferlinopathy 2022-12-05 View
AavantiBio, Inc. — target Target of the merger agreement with Solid Biosciences Inc. 2022-09-30 View
Greenland Merger Sub LLC — acquirer Wholly owned subsidiary of Solid Biosciences Inc. used to acquire AavantiBio. 2022-09-30 View
Hood Park LLC — partner Landlord for office and manufacturing space lease agreement 2021-06-16 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-06 Other Events; Exhibits View
2026-06-10 Shareholder Vote View
2026-04-10 Officer/Director Change View
2026-03-12 Regulation FD Disclosure; Other Events View
2026-03-06 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere Agreement View
2025-11-03 Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta View
2025-06-13 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-05-15 Other Events; Financial Statements and Exhibits View
2025-02-18 Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits View
2025-02-18 Other Events View
2025-02-18 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2024-06-11 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2024-01-08 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere Agreement View
2023-11-15 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2023-06-09 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2023-05-22 Departure/Election of Directors; Appointment of Officers View
2023-03-20 Regulation FD Disclosure; Financial Statements and Exhibits View
2023-03-13 Regulation FD Disclosure View
2023-01-09 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2022-12-05 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Costs Agreement Acquisition View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms